About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Liver International
›
top-articles
Liver International
5.2
(top 5%)
impact factor
5.1K
(top 5%)
papers
161.4K
(top 5%)
citations
134
(top 5%)
h
-index
5.4
(top 5%)
impact factor
6.2K
all documents
171.9K
doc citations
217
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test
Liver International
2004
7,546
2
The global burden of hepatitis C
Liver International
2009
1,150
3
Global patterns of hepatocellular carcinoma management from diagnosis to death: the
BRIDGE
Study
Liver International
2015
813
4
Diagnosis and phenotypic classification of Wilson disease1
Liver International
2003
726
5
Role of Kupffer cells in host defense and liver disease
Liver International
2006
707
6
Liver injury during highly pathogenic human coronavirus infections
Liver International
2020
680
7
The epidemiology of non‐alcoholic fatty liver disease
Liver International
2017
503
8
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Liver International
2011
481
9
Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B
Liver International
2009
432
10
Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus
Liver International
2009
427
11
Cholangiocarcinoma: Epidemiology and risk factors
Liver International
2019
420
12
Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity
Liver International
2012
396
13
Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China
Liver International
2020
388
14
Meta‐analysis:
ARFI
elastography versus transient elastography for the evaluation of liver fibrosis
Liver International
2013
370
15
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Liver International
2020
362
16
Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening
Liver International
2018
361
17
Hepatitis C virus infection in USA: an estimate of true prevalence
Liver International
2011
355
18
Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment
Liver International
2008
350
19
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
Liver International
2011
337
20
Hepatitis E and pregnancy: understanding the pathogenesis
Liver International
2008
336
21
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Liver International
2011
333
22
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
Liver International
2019
327
23
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
Liver International
2005
313
24
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients
Liver International
2010
313
25
Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (
CAP
) and transient elastography
Liver International
2012
303
26
Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future
Liver International
2018
297
27
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
Liver International
2009
294
28
Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis
Liver International
2012
284
29
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
Liver International
2012
283
30
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Liver International
2020
274
31
Pathophysiological mechanisms of liver injury in COVID‐19
Liver International
2021
273
32
Safety and efficacy of sofosbuvir‐containing regimens in hepatitis C‐infected patients with impaired renal function
Liver International
2016
270
33
Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long‐term results of a randomized multicentre study
Liver International
2007
264
34
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Liver International
2010
258
35
Experimental models of hepatic encephalopathy: ISHEN guidelines
Liver International
2009
254
36
Bilirubin in clinical practice: a review
Liver International
2008
252
37
Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
Liver International
2020
252
38
COVID‐19 and liver disease
Liver International
2020
252
39
Pathology of non‐alcoholic fatty liver disease
Liver International
2017
247
40
Predictive value of
ALT
levels for non‐alcoholic steatohepatitis (
NASH
) and advanced fibrosis in non‐alcoholic fatty liver disease (
NAFLD
)
Liver International
2013
245
41
Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosis
Liver International
2006
238
42
Nutritional status: its influence on the outcome of patients undergoing liver transplantation
Liver International
2010
233
43
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Liver International
2003
231
44
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
Liver International
2008
231
45
The pan‐caspase inhibitor Emricasan (
IDN
‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis
Liver International
2015
231
46
Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures
Liver International
2006
230
47
Angiogenesis in chronic liver disease and its complications
Liver International
2011
226
48
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
Liver International
2010
225
49
Consensus on extra-hepatic portal vein obstruction
Liver International
2006
224
50
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations
Liver International
2020
220
site/software ©
exaly
; All materials licenced under
CC by-SA
.